Recruiting
Cytomegalovirus infection+1
RecruitingStudy on Letermovir for Preventing Cytomegalovirus in Stem Cell Transplant Patients with CMV-Positive Donors
Registered drugNo placebo
Study on Letermovir for Preventing Cytomegalovirus in Stem Cell Transplant Patients with CMV-Positive Donors
Registered drugNo placebo
- Disease:Cytomegalovirus infectionAllogenic stem cell transplantation
- Substances:Letermovir
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Letermovir
- Sponsor:Grupo Espanol De Trasplante Hematopoyetico Y Terapia Celular
